Wall Street Today | Monday Market Climbs, But Not Past Last Weeks Fall
Vir Biotechnology Announces Closing Of Exclusive Worldwide License Agreement With Sanofi For Multiple Potential Best-In-Class Clinical-Stage T-Cell Engagers; Strategic Agreement Expands Vir Portfolio With Three Clinical Stage Assets In Areas Of High...
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
AstraZeneca PLC Shares Are Trading Lower After the Company Announced That Datopotamab Deruxtecan Did Not Reach Statistical Significance and Did Not Show an Overall Survival Improvement.
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today